Your browser doesn't support javascript.
loading
[Successful treatment of high-risk pulmonary embolism with low-dose anticoagulation: a case report].
Fan, S X; Cai, Q Y; Wang, X H; Li, Q; Chen, H.
Affiliation
  • Fan SX; Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
  • Cai QY; Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
  • Wang XH; Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
  • Li Q; Department of Radiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
  • Chen H; Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Zhonghua Jie He He Hu Xi Za Zhi ; 47(5): 450-454, 2024 May 12.
Article in Zh | MEDLINE | ID: mdl-38706067
ABSTRACT
Reperfusion is considered as the cornerstone of the treatment of high-risk pulmonary embolism (PE). However, when thrombolysis is contraindicated and surgery or interventional therapy is not available, the treatment of high-risk PE becomes very difficult. To our knowledge, there are no reports of successful treatment of high-risk PE with low-dose anticoagulation. On November 30, 2021, a 56-year-old male patient with subarachnoid hemorrhage was admitted to the emergency department of the First Affiliated Hospital of Chongqing Medical University. On the second day of admission, the patient suddenly went into shock during aneurysm clipping. After implementing D-dimer, markers of myocardial injury, echocardiography and computed tomography pulmonary angiography, a high-risk PE was diagnosed. Due to the contraindication of thrombolysis and the refusal of endovascular treatment, he was eventually cured with low-dose anticoagulation combined with vasopressors.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Pulmonary Embolism / Anticoagulants Limits: Humans / Male / Middle aged Language: Zh Journal: Zhonghua Jie He He Hu Xi Za Zhi Year: 2024 Type: Article Affiliation country: China

Full text: 1 Database: MEDLINE Main subject: Pulmonary Embolism / Anticoagulants Limits: Humans / Male / Middle aged Language: Zh Journal: Zhonghua Jie He He Hu Xi Za Zhi Year: 2024 Type: Article Affiliation country: China